Global Messenger RNA Vaccines and Therapeutics market size is predicted to grow from US$ 14620 million in 2025 to US$ 30550 million in 2031; it is expected to grow at a CAGR of 13.1% from 2025 to 2031.

Global Messenger RNA Vaccines and Therapeutics Market Size, Share and Analysis

The global Messenger RNA Vaccines and Therapeutics market size is predicted to grow from US$ 14620 million in 2025 to US$ 30550 million in 2031; it is expected to grow at a CAGR of 13.1% from 2025 to 2031. An mRNA vaccine is a vaccine that uses a molecular copy of messenger RNA to generate an immune response. [1] Such vaccines deliver antigen-coding mRNA molecules into immune cells, which use the designed mRNA as a template to build foreign proteins normally produced by pathogens such as viruses or cancer cells. These protein molecules stimulate an adaptive immune response, teaching the body to recognize and destroy the corresponding pathogen or cancer cell. mRNA is composed of RNA encapsulated in lipid nanoparticles, which protect the RNA strand and facilitate its uptake into cells. Reactogenicity, the propensity of the vaccine to produce adverse reactions, was similar to that of traditional non-RNA vaccines. People prone to autoimmune reactions may experience adverse reactions to messenger RNA vaccines. Compared with traditional vaccines, mRNA vaccines have the advantages of being easy to design, fast in production, low in cost, capable of inducing cellular and humoral immunity, and not interacting with genomic DNA. United States market for Messenger RNA Vaccines and Therapeutics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Messenger RNA Vaccines and Therapeutics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Messenger RNA Vaccines and Therapeutics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Messenger RNA Vaccines and Therapeutics players cover BioNTech, Moderna, CureVac, Pfizer, Glaxo Smith Klines, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. LPI (LP Information) newest research report, the Messenger RNA Vaccines and Therapeutics Industry Forecast looks at past sales and reviews total world Messenger RNA Vaccines and Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Messenger RNA Vaccines and Therapeutics sales for 2025 through 2031. With Messenger RNA Vaccines and Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Messenger RNA Vaccines and Therapeutics industry. This Insight Report provides a comprehensive analysis of the global Messenger RNA Vaccines and Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Messenger RNA Vaccines and Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Messenger RNA Vaccines and Therapeutics market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Messenger RNA Vaccines and Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Messenger RNA Vaccines and Therapeutics. This report presents a comprehensive overview, market shares, and growth opportunities of Messenger RNA Vaccines and Therapeutics market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Self-amplifying &nbsp;&nbsp;&nbsp; Conventional Non-amplifying Segmentation by Application: &nbsp;&nbsp;&nbsp; Cancer &nbsp;&nbsp;&nbsp; Infectious Diseases &nbsp;&nbsp;&nbsp; Autoimmune Diseases &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; BioNTech &nbsp;&nbsp;&nbsp; Moderna &nbsp;&nbsp;&nbsp; CureVac &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; Glaxo Smith Klines &nbsp;&nbsp;&nbsp; Daiichi Sankyo Company &nbsp;&nbsp;&nbsp; Intellia Therapeutics &nbsp;&nbsp;&nbsp; Arcturus Therapeutics &nbsp;&nbsp;&nbsp; Emmy Vaccine &nbsp;&nbsp;&nbsp; CSPC &nbsp;&nbsp;&nbsp; CanSino &nbsp;&nbsp;&nbsp; Fosun Pharma

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Messenger RNA Vaccines and Therapeutics Market Size (2020-2031) &nbsp;2.1.2 Messenger RNA Vaccines and Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Messenger RNA Vaccines and Therapeutics by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Messenger RNA Vaccines and Therapeutics Segment by Type &nbsp;2.2.1 Self-amplifying &nbsp;2.2.2 Conventional Non-amplifying &nbsp;2.3 Messenger RNA Vaccines and Therapeutics Market Size by Type &nbsp;2.3.1 Messenger RNA Vaccines and Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Messenger RNA Vaccines and Therapeutics Market Size Market Share by Type (2020-2025) &nbsp;2.4 Messenger RNA Vaccines and Therapeutics Segment by Application &nbsp;2.4.1 Cancer &nbsp;2.4.2 Infectious Diseases &nbsp;2.4.3 Autoimmune Diseases &nbsp;2.4.4 Others &nbsp;2.5 Messenger RNA Vaccines and Therapeutics Market Size by Application &nbsp;2.5.1 Messenger RNA Vaccines and Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Messenger RNA Vaccines and Therapeutics Market Size Market Share by Application (2020-2025) 3 Messenger RNA Vaccines and Therapeutics Market Size by Player &nbsp;3.1 Messenger RNA Vaccines and Therapeutics Market Size Market Share by Player &nbsp;3.1.1 Global Messenger RNA Vaccines and Therapeutics Revenue by Player (2020-2025) &nbsp;3.1.2 Global Messenger RNA Vaccines and Therapeutics Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Messenger RNA Vaccines and Therapeutics Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Messenger RNA Vaccines and Therapeutics by Region &nbsp;4.1 Messenger RNA Vaccines and Therapeutics Market Size by Region (2020-2025) &nbsp;4.2 Global Messenger RNA Vaccines and Therapeutics Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Messenger RNA Vaccines and Therapeutics Market Size Growth (2020-2025) &nbsp;4.4 APAC Messenger RNA Vaccines and Therapeutics Market Size Growth (2020-2025) &nbsp;4.5 Europe Messenger RNA Vaccines and Therapeutics Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Messenger RNA Vaccines and Therapeutics Market Size by Country (2020-2025) &nbsp;5.2 Americas Messenger RNA Vaccines and Therapeutics Market Size by Type (2020-2025) &nbsp;5.3 Americas Messenger RNA Vaccines and Therapeutics Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Messenger RNA Vaccines and Therapeutics Market Size by Region (2020-2025) &nbsp;6.2 APAC Messenger RNA Vaccines and Therapeutics Market Size by Type (2020-2025) &nbsp;6.3 APAC Messenger RNA Vaccines and Therapeutics Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Messenger RNA Vaccines and Therapeutics Market Size by Country (2020-2025) &nbsp;7.2 Europe Messenger RNA Vaccines and Therapeutics Market Size by Type (2020-2025) &nbsp;7.3 Europe Messenger RNA Vaccines and Therapeutics Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Messenger RNA Vaccines and Therapeutics by Region (2020-2025) &nbsp;8.2 Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Messenger RNA Vaccines and Therapeutics Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Messenger RNA Vaccines and Therapeutics Market Forecast &nbsp;10.1 Global Messenger RNA Vaccines and Therapeutics Forecast by Region (2026-2031) &nbsp;10.1.1 Global Messenger RNA Vaccines and Therapeutics Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Messenger RNA Vaccines and Therapeutics Forecast &nbsp;10.1.3 APAC Messenger RNA Vaccines and Therapeutics Forecast &nbsp;10.1.4 Europe Messenger RNA Vaccines and Therapeutics Forecast &nbsp;10.1.5 Middle East & Africa Messenger RNA Vaccines and Therapeutics Forecast &nbsp;10.2 Americas Messenger RNA Vaccines and Therapeutics Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Messenger RNA Vaccines and Therapeutics Forecast &nbsp;10.2.2 Canada Market Messenger RNA Vaccines and Therapeutics Forecast &nbsp;10.2.3 Mexico Market Messenger RNA Vaccines and Therapeutics Forecast &nbsp;10.2.4 Brazil Market Messenger RNA Vaccines and Therapeutics Forecast &nbsp;10.3 APAC Messenger RNA Vaccines and Therapeutics Forecast by Region (2026-2031) &nbsp;10.3.1 China Messenger RNA Vaccines and Therapeutics Market Forecast &nbsp;10.3.2 Japan Market Messenger RNA Vaccines and Therapeutics Forecast &nbsp;10.3.3 Korea Market Messenger RNA Vaccines and Therapeutics Forecast &nbsp;10.3.4 Southeast Asia Market Messenger RNA Vaccines and Therapeutics Forecast &nbsp;10.3.5 India Market Messenger RNA Vaccines and Therapeutics Forecast &nbsp;10.3.6 Australia Market Messenger RNA Vaccines and Therapeutics Forecast &nbsp;10.4 Europe Messenger RNA Vaccines and Therapeutics Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Messenger RNA Vaccines and Therapeutics Forecast &nbsp;10.4.2 France Market Messenger RNA Vaccines and Therapeutics Forecast &nbsp;10.4.3 UK Market Messenger RNA Vaccines and Therapeutics Forecast &nbsp;10.4.4 Italy Market Messenger RNA Vaccines and Therapeutics Forecast &nbsp;10.4.5 Russia Market Messenger RNA Vaccines and Therapeutics Forecast &nbsp;10.5 Middle East & Africa Messenger RNA Vaccines and Therapeutics Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Messenger RNA Vaccines and Therapeutics Forecast &nbsp;10.5.2 South Africa Market Messenger RNA Vaccines and Therapeutics Forecast &nbsp;10.5.3 Israel Market Messenger RNA Vaccines and Therapeutics Forecast &nbsp;10.5.4 Turkey Market Messenger RNA Vaccines and Therapeutics Forecast &nbsp;10.6 Global Messenger RNA Vaccines and Therapeutics Forecast by Type (2026-2031) &nbsp;10.7 Global Messenger RNA Vaccines and Therapeutics Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Messenger RNA Vaccines and Therapeutics Forecast 11 Key Players Analysis &nbsp;11.1 BioNTech &nbsp;11.1.1 BioNTech Company Information &nbsp;11.1.2 BioNTech Messenger RNA Vaccines and Therapeutics Product Offered &nbsp;11.1.3 BioNTech Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 BioNTech Main Business Overview &nbsp;11.1.5 BioNTech Latest Developments &nbsp;11.2 Moderna &nbsp;11.2.1 Moderna Company Information &nbsp;11.2.2 Moderna Messenger RNA Vaccines and Therapeutics Product Offered &nbsp;11.2.3 Moderna Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Moderna Main Business Overview &nbsp;11.2.5 Moderna Latest Developments &nbsp;11.3 CureVac &nbsp;11.3.1 CureVac Company Information &nbsp;11.3.2 CureVac Messenger RNA Vaccines and Therapeutics Product Offered &nbsp;11.3.3 CureVac Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 CureVac Main Business Overview &nbsp;11.3.5 CureVac Latest Developments &nbsp;11.4 Pfizer &nbsp;11.4.1 Pfizer Company Information &nbsp;11.4.2 Pfizer Messenger RNA Vaccines and Therapeutics Product Offered &nbsp;11.4.3 Pfizer Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 Pfizer Main Business Overview &nbsp;11.4.5 Pfizer Latest Developments &nbsp;11.5 Glaxo Smith Kline's &nbsp;11.5.1 Glaxo Smith Kline's Company Information &nbsp;11.5.2 Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Product Offered &nbsp;11.5.3 Glaxo Smith Kline's Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Glaxo Smith Kline's Main Business Overview &nbsp;11.5.5 Glaxo Smith Kline's Latest Developments &nbsp;11.6 Daiichi Sankyo Company &nbsp;11.6.1 Daiichi Sankyo Company Company Information &nbsp;11.6.2 Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Product Offered &nbsp;11.6.3 Daiichi Sankyo Company Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Daiichi Sankyo Company Main Business Overview &nbsp;11.6.5 Daiichi Sankyo Company Latest Developments &nbsp;11.7 Intellia Therapeutics &nbsp;11.7.1 Intellia Therapeutics Company Information &nbsp;11.7.2 Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Product Offered &nbsp;11.7.3 Intellia Therapeutics Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 Intellia Therapeutics Main Business Overview &nbsp;11.7.5 Intellia Therapeutics Latest Developments &nbsp;11.8 Arcturus Therapeutics &nbsp;11.8.1 Arcturus Therapeutics Company Information &nbsp;11.8.2 Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Product Offered &nbsp;11.8.3 Arcturus Therapeutics Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 Arcturus Therapeutics Main Business Overview &nbsp;11.8.5 Arcturus Therapeutics Latest Developments &nbsp;11.9 Emmy Vaccine &nbsp;11.9.1 Emmy Vaccine Company Information &nbsp;11.9.2 Emmy Vaccine Messenger RNA Vaccines and Therapeutics Product Offered &nbsp;11.9.3 Emmy Vaccine Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.9.4 Emmy Vaccine Main Business Overview &nbsp;11.9.5 Emmy Vaccine Latest Developments &nbsp;11.10 CSPC &nbsp;11.10.1 CSPC Company Information &nbsp;11.10.2 CSPC Messenger RNA Vaccines and Therapeutics Product Offered &nbsp;11.10.3 CSPC Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.10.4 CSPC Main Business Overview &nbsp;11.10.5 CSPC Latest Developments &nbsp;11.11 CanSino &nbsp;11.11.1 CanSino Company Information &nbsp;11.11.2 CanSino Messenger RNA Vaccines and Therapeutics Product Offered &nbsp;11.11.3 CanSino Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.11.4 CanSino Main Business Overview &nbsp;11.11.5 CanSino Latest Developments &nbsp;11.12 Fosun Pharma &nbsp;11.12.1 Fosun Pharma Company Information &nbsp;11.12.2 Fosun Pharma Messenger RNA Vaccines and Therapeutics Product Offered &nbsp;11.12.3 Fosun Pharma Messenger RNA Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.12.4 Fosun Pharma Main Business Overview &nbsp;11.12.5 Fosun Pharma Latest Developments 12 Research Findings and Conclusion

Report	Global Messenger RNA Vaccines and Therapeutics Market Growth, Trends and Opportunities 2025-31
Selected License	Multi ID: LPI50218

Buyer Information

Order Summary